What is the address of NUCARE?

The registered office of NUCARE is located at Meersstraat 86, 1770 Liedekerke.

Is NUCARE still active?

Yes. According to the CBE (30 October 2026) NUCARE is active, legal situation “Normale toestand”, started on 7 December 2012.

Is NUCARE registered on Peppol?

Yes, NUCARE is registered on the Peppol network with ID 0208:0501828213.

What is the enterprise number of NUCARE?

The enterprise number of NUCARE is BE0501828213.

When was NUCARE founded?

NUCARE was founded on 7 December 2012.

Who are the directors of NUCARE?

According to the 2025 annual accounts, the directors of NUCARE are: Généreuse NSANZIMANA.

Is NUCARE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 December 2012; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did NUCARE make in 2025?

NUCARE posted a profit after taxes of € 24,507 in financial year 2025.

What is the revenue of NUCARE?

As a small company, NUCARE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 43,796.

NUCARE (Private Limited) - Liedekerke - BE0501828213

Dossier NUCARE, printed on 30 October 2026 from databakkes.be/en/0501828213/nucare. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

NUCARE from Liedekerke, company number BE0501828213, closed financial year 2025 with a result of € 24,507 after tax. For that financial year NUCARE recorded a gross margin of € 43,796 and equity of € 34,477. Compared with financial year 2024, the result moved from € -5,881 to € 24,507. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Growing

€ 34,477

▲ 246% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 24,507

▲ still € 5,881 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 27,531

▲ € 23,212 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 28,277.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 5,025

▼ 50% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 8,639

▼ 32% vs 2024

€ 4,198 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Taxes

€ 13,218

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -15,902 Gross margin 2022: € -15,902 First fiscal year in the series	€ -10,797 Gross margin 2023: € -10,797 ▲ € 5,106 vs 2022 (€ -15,902) Favourable step	€ 621 Gross margin 2024: € 621 ▲ € 11,418 vs 2023 (€ -10,797) Favourable step	€ 43,796 Gross margin 2025: € 43,796 ▲ € 43,175 vs 2024 (€ 621) Favourable step	▲ € 43,175
Profit after taxes	€ -21,898 Profit after taxes 2022: € -21,898 First fiscal year in the series	€ -17,342 Profit after taxes 2023: € -17,342 ▲ € 4,555 vs 2022 (€ -21,898) Favourable step	€ -5,881 Profit after taxes 2024: € -5,881 ▲ € 11,461 vs 2023 (€ -17,342) Favourable step	€ 24,507 Profit after taxes 2025: € 24,507 ▲ € 30,389 vs 2024 (€ -5,881) Favourable step	▲ € 30,389
Equity	€ 33,194 Equity 2022: € 33,194 First fiscal year in the series	€ 15,851 Equity 2023: € 15,851 ▼ 52% vs 2022 (€ 33,194) Unfavourable step	€ 9,970 Equity 2024: € 9,970 ▼ 37% vs 2023 (€ 15,851) Unfavourable step	€ 34,477 Equity 2025: € 34,477 ▲ 246% vs 2024 (€ 9,970) Favourable step	▲ 246%
Total debts	€ 20,818 Total debts 2022: € 20,818 First fiscal year in the series	€ 16,826 Total debts 2023: € 16,826 ▼ 19% vs 2022 (€ 20,818) Favourable step	€ 12,767 Total debts 2024: € 12,767 ▼ 24% vs 2023 (€ 16,826) Favourable step	€ 21,857 Total debts 2025: € 21,857 ▲ 71% vs 2024 (€ 12,767) Unfavourable step	▲ 71%
Cash	€ 4,007 Cash 2022: € 4,007 First fiscal year in the series	€ 7,469 Cash 2023: € 7,469 ▲ 86% vs 2022 (€ 4,007) Favourable step	€ 4,319 Cash 2024: € 4,319 ▼ 42% vs 2023 (€ 7,469) Unfavourable step	€ 27,531 Cash 2025: € 27,531 ▲ € 23,212 vs 2024 (€ 4,319) Favourable step	▲ € 23,212
Retained profit	€ 26,994 Retained profit 2022: € 26,994 First fiscal year in the series	€ 9,651 Retained profit 2023: € 9,651 ▼ 64% vs 2022 (€ 26,994) Unfavourable step	€ 3,770 Retained profit 2024: € 3,770 ▼ 61% vs 2023 (€ 9,651) Unfavourable step	€ 28,277 Retained profit 2025: € 28,277 ▲ € 24,507 vs 2024 (€ 3,770) Favourable step	▲ € 24,507
Bank debt	€ 20,818 Bank debt 2022: € 20,818 First fiscal year in the series	€ 16,826 Bank debt 2023: € 16,826 ▼ 19% vs 2022 (€ 20,818) Favourable step	€ 12,767 Bank debt 2024: € 12,767 ▼ 24% vs 2023 (€ 16,826) Favourable step	€ 8,639 Bank debt 2025: € 8,639 ▼ 32% vs 2024 (€ 12,767) Favourable step	▼ 32%
Balance sheet total	€ 54,012 Balance sheet total 2022: € 54,012 First fiscal year in the series	€ 32,678 Balance sheet total 2023: € 32,678 ▼ 39% vs 2022 (€ 54,012) Unchanged	€ 22,737 Balance sheet total 2024: € 22,737 ▼ 30% vs 2023 (€ 32,678) Unchanged	€ 56,335 Balance sheet total 2025: € 56,335 ▲ 148% vs 2024 (€ 22,737) Unchanged	▲ 148%

Key figures of NUCARE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to NUCARE?

What happened at NUCARE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 2, 2026 New annual accounts for financial year 2025: profit of € 24,507. Source: NBB ↗
2012 Généreuse NSANZIMANA became a director. NBB
Dec 7, 2012 New establishment in Liedekerke. KBO
Dec 7, 2012 Start of the company according to the CBE. KBO

In short

From € 21,898 loss in 2022 to € 24,507 profit in 2025.

Paid € 13,232 in corporate taxes since 2022.

Best year ever: 2025, with € 24,507 profit.

Original PDFs at the National Bank ↗

Management

Généreuse NSANZIMANA

NUCARE

Behind NUCARE is Généreuse NSANZIMANA.

Directors

According to the 2025 annual accounts

Généreuse NSANZIMANA

Director

since 2012

Establishments

Establishment units

Physical locations of this company

Registered office

Meersstraat 86

1770 Liedekerke

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0501.828.213
VAT number: BE 0501.828.213
Registered office: Meersstraat 86, 1770 Liedekerke
Names & denominations: NUCARE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 7 December 2012
Peppol: Active · Active since 8 Sept 2026

View on CBE Public ↗ Annual accounts (NBB) ↗